Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Mountain Crest Acquisition Corp. V Announces Closing of Fully-Exercised Over-Allotment Option in Connection with Its Initial Public Offering
-
IPO for SPAC Arisz Acquisition Corp. (ARIZ) Opens at $10.11
-
Arisz Acquisition Corp. (ARIZ) Prices 6M Unit IPO at $10/unit
-
Arisz Acquisition Corp. Announces Pricing of $60 Million Initial Public Offering on NASDAQ
-
Arisz Acquisition Corp. Announces Pricing of $60 Million Initial Public Offering on NASDAQ
-
Monterey Bio Acquisition Corporation Announces the Separate Trading of its Common Stock and Warrants, Commencing November 22, 2021
-
Mountain Crest Acquisition Corp. V Announces Closing of $60 Million Initial Public Offering
-
Form 10-Q Chardan NexTech Acquisit For: Sep 30
-
Renovacor Announces Third Quarter 2021 Financial Results and Provides Corporate Update
-
Quantum FinTech Acquisition Corporation Announces Co-Placement Agents for PIPE Associated with Proposed Initial Business Combination
-
Quantum FinTech Acquisition Corporation Announces Co-Placement Agents for PIPE Associated with Proposed Initial Business Combination
-
Celsion Corporation Reports Third Quarter 2021 Financial Results and Provides Business Update
-
Celsion Corporation Reports Third Quarter 2021 Financial Results and Provides Business Update
-
AgeX Therapeutics Reports Third Quarter 2021 Financial Results
-
Mountain Crest Acquisition Corp. V (MCAGU) Prices 6M Unit IPO at $10/unit
-
Mountain Crest Acquisition Corp. V Announces Pricing of $60 Million Initial Public Offering
-
Kaleido Biosciences Inc. (KLDO) PT Lowered to $11 at Chardan Capital Markets
-
Emergent BioSolutions (EBS) PT Lowered to $75 at Chardan Capital Markets
-
Presto to be Publicly Listed Through Merger With Ventoux CCM Acquisition (VTAQ)
-
Presto, a Leading Provider of Restaurant Labor Productivity Technologies, to be Publicly Listed Through a Merger With Ventoux CCM Acquisition Corp (NASDAQ: VTAQ)
-
Chardan Capital Markets Starts SAB Biotherapeutics (SABS) at Buy
-
Regenxbio Inc. (RGNX) PT Lowered to $90 at Chardan Capital Markets
-
Blockchain Moon Acquisition Corp. Announces the Separate Trading of its Common Stock, Rights and Warrants, Commencing November 3, 2021
-
Blockchain Moon Acquisition Corp. Announces the Separate Trading of its Common Stock, Rights and Warrants, Commencing November 3, 2021
-
UPDATE: Chardan Capital Markets Upgrades Evelo Biosciences Inc (EVLO) to Buy
-
UPDATE - Lottery.com and Trident Acquisitions Corp. Announce Closing of Business Combination
-
Better Therapeutics Closes Business Combination and Debuts on Nasdaq
-
Blockchain Moon Acquisition Corp. Announces Closing of Over-Allotment Option in Connection With Its Initial Public Offering
-
Blockchain Moon Acquisition Corp. Announces Closing of Over-Allotment Option in Connection With Its Initial Public Offering
-
Form S-1/A CHARDAN NEXTECH ACQUISIT
-
Pear Therapeutics and Thimble Point Acquisition Corp. Announce Effectiveness of S-4 Registration Statement and Set November 23, 2021 for Thimble Point Special Stockholder Meeting to Vote on Proposed B
-
SAB Biotherapeutics Debuts as Publicly Traded Next-Generation Immunotherapy Company
-
SAB Biotherapeutics Debuts as Publicly Traded Next-Generation Immunotherapy Company
-
Blockchain Moon Acquisition Corp. Announces Closing of $100 Million Initial Public Offering
-
Blockchain Moon Acquisition Corp. Announces Closing of $100 Million Initial Public Offering
-
BiomX (PHGE) PT Lowered to $16 at Chardan Capital Markets
-
Blockchain Moon Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering
-
Blockchain Moon Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering
-
Form S-1/A CHARDAN NEXTECH ACQUISIT
-
IPO for SPAC Achari Ventures Holdings Corp. I (AVHI) Opens at $10.05
-
Achari Ventures Holdings Corp (AVHIU) Prices 10M Unit IPO at $10/unit
-
Achari Ventures Holdings Corp. I Announces Pricing of $100 Million Initial Public Offering
-
Best Penny Stocks To Buy This Week? 10 With Potential Biotech Catalysts
-
Monterey Bio Acquisition Corporation Announces Closing of Initial Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Units
-
Exicure to Present at the Chardan Virtual 5th Annual Genetic Medicines Conference
-
Scout Bio to Present at Upcoming October Investor Conferences
-
Scout Bio to Present at Upcoming October Investor Conferences
-
Clinical Data on GenSight Biologics’ LUMEVOQ® and GS030 Gene Therapies to be Presented at 2021 ASRS, ESGCT and Several Investor and Industry Meetings in October
-
Krystal Biotech to Present at the Chardan 5th Annual Genetic Medicines Conference
-
UPDATE: Chardan Capital Markets Starts Renovacor, Inc. (RCOR) at Buy

